Tabula Rasa Healthcare Stock Price, News & Analysis (NASDAQ:TRHC)

$35.73 1.19 (3.45 %)
(As of 11/21/2017 04:00 PM ET)
Previous Close$34.54
Today's Range$34.55 - $36.59
52-Week Range$11.35 - $36.59
Volume159,013 shs
Average Volume91,959 shs
Market Capitalization$615.08 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Tabula Rasa Healthcare (NASDAQ:TRHC)

Tabula Rasa Healthcare logoTabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient's acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.


Industry, Sector and Symbol:
  • Industry: Medical Software & Technology Services
  • Sub-Industry: N/A
  • Sector: Healthcare
  • Symbol: NASDAQ:TRHC
  • CUSIP: N/A
  • Web: www.tabularasahealthcare.com
Debt:
  • Debt-to-Equity Ratio: 0.47%
  • Current Ratio: 0.73%
  • Quick Ratio: 0.66%
Price-To-Earnings:
  • Forward P/E Ratio: 714.60
  • P/E Growth: 27.63
Sales & Book Value:
  • Annual Sales: $94.06 million
  • Price / Sales: 6.78
  • Cash Flow: $0.39 per share
  • Price / Cash: 90.50
  • Book Value: $3.48 per share
  • Price / Book: 10.27
Profitability:
  • Trailing EPS: ($0.17)
  • Net Income: $-6,250,000.00
  • Net Margins: -2.27%
  • Return on Equity: -5.58%
  • Return on Assets: -3.49%
Misc:
  • Employees: 241
  • Outstanding Shares: 17,850,000
 

Frequently Asked Questions for Tabula Rasa Healthcare (NASDAQ:TRHC)

What is Tabula Rasa Healthcare's stock symbol?

Tabula Rasa Healthcare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa Healthcare's earnings last quarter?

Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) released its quarterly earnings data on Monday, November, 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.06 by $0.02. The company earned $33.27 million during the quarter, compared to the consensus estimate of $31.76 million. Tabula Rasa Healthcare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The firm's revenue was up 37.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.06 earnings per share. View Tabula Rasa Healthcare's Earnings History.

When will Tabula Rasa Healthcare make its next earnings announcement?

Tabula Rasa Healthcare is scheduled to release their next quarterly earnings announcement on Monday, March, 12th 2018. View Earnings Estimates for Tabula Rasa Healthcare.

Where is Tabula Rasa Healthcare's stock going? Where will Tabula Rasa Healthcare's stock price be in 2017?

6 equities research analysts have issued 12-month price objectives for Tabula Rasa Healthcare's stock. Their forecasts range from $16.00 to $41.00. On average, they anticipate Tabula Rasa Healthcare's share price to reach $28.33 in the next year. View Analyst Ratings for Tabula Rasa Healthcare.

What are Wall Street analysts saying about Tabula Rasa Healthcare stock?

Here are some recent quotes from research analysts about Tabula Rasa Healthcare stock:

  • 1. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (11/10/2017)
  • 2. Piper Jaffray Companies analysts commented, "Tabula Rasa reported another strong revenue quarter but guided 1Q17 profitability slightly below expectations in order to ramp up operations to meet the needs of new large accounts. We believe this investment will be leveraged over time because it's supporting the growth of higher margin business, and will also gain efficiency over time. We are reiterating OW, and raising PT to $19 from $18." (3/14/2017)
  • 3. Stifel Nicolaus analysts commented, "On March 13, 2017, Tabula Rasa (TRHC) announced strong results for 4Q16 and full year. 2017 guidance for revenue and adjusted-EBITDA was established in and around expectations but fell slightly short of our modeling. Management provided an update of the operations and key customers along with quarterly remarks and an update on new business. We believe TRHC is a company with unique products that will have an interested audience in coming years given unrelenting healthcare trends that are agnostic to political party. TRHC is Buy-rated. Raise target to $19 (from $17) based on combination of price-to-sales and EV-EBITDA multiples." (3/14/2017)

Who are some of Tabula Rasa Healthcare's key competitors?

Who are Tabula Rasa Healthcare's key executives?

Tabula Rasa Healthcare's management team includes the folowing people:

  • Calvin H. Knowlton Ph.D., Chairman of the Board, Chief Executive Officer, Co-Founder (Age 67)
  • Orsula Voltis Knowlton, President, Co-Founder, Director (Age 49)
  • Brian W. Adams, Chief Financial Officer (Age 36)
  • Samira K. Beckwith, Director (Age 64)
  • Glen R. Bressner, Independent Director (Age 56)
  • Dennis K. Helling, Independent Director (Age 68)
  • Daniel C. Lubin, Independent Director (Age 57)
  • Bruce H. Luehrs, Independent Director (Age 63)

When did Tabula Rasa Healthcare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Who owns Tabula Rasa Healthcare stock?

Tabula Rasa Healthcare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Hood River Capital Management LLC (4.23%), Pier Capital LLC (0.87%), Wasatch Advisors Inc. (0.85%), EAM Investors LLC (0.82%), Allianz Asset Management GmbH (0.80%) and Paradigm Capital Management Inc. NY (0.45%). Company insiders that own Tabula Rasa Healthcare stock include Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Joann M Durham and Orsula V Knowlton. View Institutional Ownership Trends for Tabula Rasa Healthcare.

Who sold Tabula Rasa Healthcare stock? Who is selling Tabula Rasa Healthcare stock?

Tabula Rasa Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Hood River Capital Management LLC. Company insiders that have sold Tabula Rasa Healthcare company stock in the last year include Calvin H Knowlton, Gordon Tunstall and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa Healthcare.

Who bought Tabula Rasa Healthcare stock? Who is buying Tabula Rasa Healthcare stock?

Tabula Rasa Healthcare's stock was purchased by a variety of institutional investors in the last quarter, including Pier Capital LLC, Wasatch Advisors Inc., EAM Investors LLC, Allianz Asset Management GmbH, Cadence Capital Management LLC, JPMorgan Chase & Co., California Public Employees Retirement System and Rhumbline Advisers. View Insider Buying and Selling for Tabula Rasa Healthcare.

How do I buy Tabula Rasa Healthcare stock?

Shares of Tabula Rasa Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa Healthcare's stock price today?

One share of Tabula Rasa Healthcare stock can currently be purchased for approximately $35.73.

How big of a company is Tabula Rasa Healthcare?

Tabula Rasa Healthcare has a market capitalization of $615.08 million and generates $94.06 million in revenue each year. The company earns $-6,250,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. Tabula Rasa Healthcare employs 241 workers across the globe.

How can I contact Tabula Rasa Healthcare?

Tabula Rasa Healthcare's mailing address is 228 Strawbridge Dr Ste 100, MOORESTOWN, NJ 08057-4600, United States. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa Healthcare (NASDAQ TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  76 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  148
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Tabula Rasa Healthcare (NASDAQ:TRHC)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 5 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $28.33 (20.70% downside)

Consensus Price Target History for Tabula Rasa Healthcare (NASDAQ:TRHC)

Price Target History for Tabula Rasa Healthcare (NASDAQ:TRHC)

Analysts' Ratings History for Tabula Rasa Healthcare (NASDAQ:TRHC)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/7/2017Piper Jaffray CompaniesReiterated RatingOverweight$35.00N/AView Rating Details
11/1/2017First AnalysisInitiated CoverageOverweight$41.00N/AView Rating Details
10/19/2017Wells Fargo & CompanyBoost Price TargetMarket Perform$21.00 -> $27.00N/AView Rating Details
10/17/2017Robert W. BairdReiterated RatingOutperform$22.00 -> $30.00N/AView Rating Details
8/8/2017Chardan CapitalBoost Price TargetBuy -> Buy$19.50 -> $21.00HighView Rating Details
7/14/2017Stifel NicolausReiterated RatingBuy$16.00LowView Rating Details
(Data available from 11/21/2015 forward)

Earnings

Earnings History and Estimates Chart for Tabula Rasa Healthcare (NASDAQ:TRHC)

Earnings by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)

Earnings History by Quarter for Tabula Rasa Healthcare (NASDAQ TRHC)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018        
11/6/2017Q3 2017$0.06$0.08$31.76 million$33.27 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.06$0.06$27.84 million$29.70 millionViewListenView Earnings Details
5/1/2017Q1 2017$0.06$0.04$26.00 million$27.70 millionViewListenView Earnings Details
3/13/2017Q4 2016$0.11$0.10$25.53 million$27.30 millionViewN/AView Earnings Details
11/9/2016Q316$0.03$0.06$22.35 million$24.17 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tabula Rasa Healthcare (NASDAQ:TRHC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181$0.15$0.15$0.15
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tabula Rasa Healthcare (NASDAQ:TRHC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tabula Rasa Healthcare (NASDAQ TRHC)

Insider Ownership Percentage: 45.80%
Institutional Ownership Percentage: 28.41%
Insider Trades by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)
Institutional Ownership by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)

Insider Trades by Quarter for Tabula Rasa Healthcare (NASDAQ TRHC)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/18/2017Orsula V KnowltonInsiderSell8,000$26.68$213,440.00View SEC Filing  
9/13/2017Orsula V KnowltonInsiderSell8,000$22.10$176,800.00View SEC Filing  
8/16/2017Calvin H KnowltonCEOSell8,000$17.21$137,680.00View SEC Filing  
7/19/2017Orsula V KnowltonInsiderSell8,000$14.20$113,600.00View SEC Filing  
6/14/2017Orsula V. KnowltonInsiderSell8,000$14.02$112,160.00View SEC Filing  
6/12/2017Gordon TunstallDirectorSell22,759$13.76$313,163.84View SEC Filing  
5/18/2017Glen R BressnerDirectorBuy7,500$11.96$89,700.00View SEC Filing  
5/17/2017Orsula V KnowltonInsiderSell8,000$11.94$95,520.00View SEC Filing  
10/4/2016Glen R BressnerDirectorBuy8,500$12.00$102,000.00View SEC Filing  
10/4/2016Joann M DurhamMajor ShareholderSell4,070$12.00$48,840.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tabula Rasa Healthcare (NASDAQ TRHC)

Source:
DateHeadline
Equities Analysts Set Expectations for Tabula Rasa Healthcare Inc.s Q3 2018 Earnings (TRHC)Equities Analysts Set Expectations for Tabula Rasa Healthcare Inc.'s Q3 2018 Earnings (TRHC)
www.americanbankingnews.com - November 14 at 10:48 AM
Tabula Rasa Healthcare Inc. (TRHC) Receives Average Rating of "Buy" from BrokeragesTabula Rasa Healthcare Inc. (TRHC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 12 at 10:38 PM
Zacks Investment Research Lowers Tabula Rasa Healthcare Inc. (TRHC) to HoldZacks Investment Research Lowers Tabula Rasa Healthcare Inc. (TRHC) to Hold
www.americanbankingnews.com - November 10 at 6:58 AM
Sales Growth Keep Tabula Rasa Healthcare (TRHC) a BuySales Growth Keep Tabula Rasa Healthcare (TRHC) a Buy
investorplace.com - November 9 at 7:09 PM
Tabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial OutlookTabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial Outlook
www.nasdaq.com - November 7 at 12:21 PM
Tabula Rasa HealthCares (TRHC) CEO Calvin Knowlton on Q3 2017 Results - Earnings Call TranscriptTabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 12:21 PM
Tabula Rasa HealthCare Announces Third Quarter 2017 ResultsTabula Rasa HealthCare Announces Third Quarter 2017 Results
finance.yahoo.com - November 7 at 12:21 PM
Tabula Rasa Healthcare misses 3Q profit forecastsTabula Rasa Healthcare misses 3Q profit forecasts
finance.yahoo.com - November 7 at 12:21 PM
UPDATE -- Tabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial OutlookUPDATE -- Tabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial Outlook
finance.yahoo.com - November 7 at 12:21 PM
Piper Jaffray Companies Reaffirms Overweight Rating for Tabula Rasa Healthcare Inc. (TRHC)Piper Jaffray Companies Reaffirms Overweight Rating for Tabula Rasa Healthcare Inc. (TRHC)
www.americanbankingnews.com - November 7 at 11:16 AM
Tabula Rasa Healthcare Inc. (TRHC) Issues Quarterly  Earnings ResultsTabula Rasa Healthcare Inc. (TRHC) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 6 at 9:24 PM
$31.32 Million in Sales Expected for Tabula Rasa Healthcare Inc. (TRHC) This Quarter$31.32 Million in Sales Expected for Tabula Rasa Healthcare Inc. (TRHC) This Quarter
www.americanbankingnews.com - November 3 at 4:32 AM
First Analysis Initiates Coverage on Tabula Rasa Healthcare Inc. (TRHC)First Analysis Initiates Coverage on Tabula Rasa Healthcare Inc. (TRHC)
www.americanbankingnews.com - November 1 at 6:28 PM
Tabula Rasa Healthcare Inc. (TRHC) to Release Earnings on MondayTabula Rasa Healthcare Inc. (TRHC) to Release Earnings on Monday
www.americanbankingnews.com - October 30 at 12:42 PM
Tabula Rasa Healthcare Inc. (TRHC) Given Buy Rating at Piper Jaffray CompaniesTabula Rasa Healthcare Inc. (TRHC) Given Buy Rating at Piper Jaffray Companies
www.americanbankingnews.com - October 24 at 4:26 PM
Contrasting Tabula Rasa Healthcare (TRHC) and Its RivalsContrasting Tabula Rasa Healthcare (TRHC) and Its Rivals
www.americanbankingnews.com - October 21 at 8:15 AM
Allscripts Healthcare Solutions (MDRX) vs. Tabula Rasa Healthcare (TRHC) Critical ReviewAllscripts Healthcare Solutions (MDRX) vs. Tabula Rasa Healthcare (TRHC) Critical Review
www.americanbankingnews.com - October 20 at 12:22 PM
Orsula V. Knowlton Sells 8,000 Shares of Tabula Rasa Healthcare Inc. (TRHC) StockOrsula V. Knowlton Sells 8,000 Shares of Tabula Rasa Healthcare Inc. (TRHC) Stock
www.americanbankingnews.com - October 19 at 7:20 PM
Tabula Rasa Healthcare Inc. (TRHC) Given New $27.00 Price Target at Wells Fargo & CompanyTabula Rasa Healthcare Inc. (TRHC) Given New $27.00 Price Target at Wells Fargo & Company
www.americanbankingnews.com - October 19 at 3:08 PM
Tabula Rasa Healthcare Inc. (TRHC) Receives Average Recommendation of "Buy" from BrokeragesTabula Rasa Healthcare Inc. (TRHC) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 19 at 12:58 AM
Critical Comparison: Tabula Rasa Healthcare (TRHC) & Its CompetitorsCritical Comparison: Tabula Rasa Healthcare (TRHC) & Its Competitors
www.americanbankingnews.com - October 18 at 10:22 PM
Tabula Rasa Healthcare Inc. (TRHC) Rating Reiterated by Robert W. BairdTabula Rasa Healthcare Inc. (TRHC) Rating Reiterated by Robert W. Baird
www.americanbankingnews.com - October 17 at 9:22 AM
Tabula Rasa Healthcare to Announce Third Quarter 2017 Operating Results and Host Conference Call on Monday, November 6, 2017Tabula Rasa Healthcare to Announce Third Quarter 2017 Operating Results and Host Conference Call on Monday, November 6, 2017
finance.yahoo.com - October 17 at 8:15 AM
BRIEF-Tabula Rasa - files for mixed shelf offering of up to $200 mlnBRIEF-Tabula Rasa - files for mixed shelf offering of up to $200 mln
www.reuters.com - October 16 at 7:16 AM
Tabula Rasa HealthCare (TRHC) versus Its Peers Financial AnalysisTabula Rasa HealthCare (TRHC) versus Its Peers Financial Analysis
www.americanbankingnews.com - October 13 at 4:28 AM
Tabula Rasa Healthcare Inc. (TRHC) Stock Rating Upgraded by Zacks Investment ResearchTabula Rasa Healthcare Inc. (TRHC) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - October 11 at 3:22 PM
SinfoníaRx Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and ComplianceSinfoníaRx Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance
finance.yahoo.com - October 3 at 1:51 PM
Tabula Rasa HealthCare Reaches Analyst Target PriceTabula Rasa HealthCare Reaches Analyst Target Price
www.thestreet.com - September 29 at 11:24 AM
Tabula Rasa HealthCare Hosts 18 PACE Medical Directors at 2017 Annual Clinical Advisory Panel MeetingTabula Rasa HealthCare Hosts 18 PACE Medical Directors at 2017 Annual Clinical Advisory Panel Meeting
www.nasdaq.com - September 29 at 11:24 AM
Analyzing Tabula Rasa Healthcare (TRHC) & Its RivalsAnalyzing Tabula Rasa Healthcare (TRHC) & Its Rivals
www.americanbankingnews.com - September 26 at 6:24 AM
Tabula Rasa Healthcare Inc. (TRHC) Receives Consensus Rating of "Buy" from AnalystsTabula Rasa Healthcare Inc. (TRHC) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - September 23 at 10:48 PM
Head-To-Head Survey: Tabula Rasa Healthcare (TRHC) vs. Its RivalsHead-To-Head Survey: Tabula Rasa Healthcare (TRHC) vs. Its Rivals
www.americanbankingnews.com - September 23 at 12:16 PM
Contrasting Tabula Rasa Healthcare (TRHC) & Its CompetitorsContrasting Tabula Rasa Healthcare (TRHC) & Its Competitors
www.americanbankingnews.com - September 23 at 8:32 AM
Piper Jaffray Companies Reiterates Overweight Rating for Tabula Rasa Healthcare Inc. (TRHC)Piper Jaffray Companies Reiterates Overweight Rating for Tabula Rasa Healthcare Inc. (TRHC)
www.americanbankingnews.com - September 20 at 5:46 PM
Tabula Rasa Healthcare Inc. (TRHC) Insider Sells $176,800.00 in StockTabula Rasa Healthcare Inc. (TRHC) Insider Sells $176,800.00 in Stock
www.americanbankingnews.com - September 14 at 11:36 PM
$35M deal: Tabula Rasa buys Arizona health tech company$35M deal: Tabula Rasa buys Arizona health tech company
www.bizjournals.com - September 14 at 11:34 AM
Tabula Rasa HealthCare Subsidiary CareKinesis Receives Board Certified Geriatric Pharmacist Recognition Across All CliniciansTabula Rasa HealthCare Subsidiary CareKinesis Receives Board Certified Geriatric Pharmacist Recognition Across All Clinicians
finance.yahoo.com - September 11 at 7:49 AM
Tabula Rasa Healthcare Inc. (TRHC) Cut to "Market Perform" at Wells Fargo & CompanyTabula Rasa Healthcare Inc. (TRHC) Cut to "Market Perform" at Wells Fargo & Company
www.americanbankingnews.com - September 10 at 10:02 AM
BRIEF-Tabula Rasa Healthcare paid $35 mln to Sinfonía Healthcare after mergerBRIEF-Tabula Rasa Healthcare paid $35 mln to Sinfonía Healthcare after merger
www.reuters.com - September 8 at 8:26 PM
Tabula Rasa Healthcare (TRHC) Presents At 2017 Wells Fargo Healthcare Conference - SlideshowTabula Rasa Healthcare (TRHC) Presents At 2017 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 8 at 8:26 PM
Tabula Rasa HealthCare (TRHC) Reports Acquisition of SinfoniaRxTabula Rasa HealthCare (TRHC) Reports Acquisition of SinfoniaRx
www.streetinsider.com - September 8 at 8:26 PM
$29.67 Million in Sales Expected for Tabula Rasa Healthcare Inc. (TRHC) This Quarter$29.67 Million in Sales Expected for Tabula Rasa Healthcare Inc. (TRHC) This Quarter
www.americanbankingnews.com - September 8 at 2:58 PM
Transaction Risk Leaves Tabula Rasa HealthCare Shares With Little Upside, Stock Downgraded'Transaction Risk' Leaves Tabula Rasa HealthCare Shares With Little Upside, Stock Downgraded
finance.yahoo.com - September 8 at 9:29 AM
Tabula Rasa HealthCare Acquires SinfoníaRx Expanding its Medication Therapy Management OfferingTabula Rasa HealthCare Acquires SinfoníaRx Expanding its Medication Therapy Management Offering
finance.yahoo.com - September 7 at 10:09 AM
Financial Analysis: Tabula Rasa Healthcare (TRHC) vs. Castlight Health, inc. (CSLT)Financial Analysis: Tabula Rasa Healthcare (TRHC) vs. Castlight Health, inc. (CSLT)
www.americanbankingnews.com - August 31 at 12:23 AM
Tabula Rasa Healthcare Inc. (TRHC) Price Target Increased to $25.00 by Analysts at UBS AGTabula Rasa Healthcare Inc. (TRHC) Price Target Increased to $25.00 by Analysts at UBS AG
www.americanbankingnews.com - August 30 at 11:36 AM
Tabula Rasa Healthcare Inc. (TRHC) Given Average Recommendation of "Buy" by BrokeragesTabula Rasa Healthcare Inc. (TRHC) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - August 29 at 10:50 PM
BRIEF-Tabula Rasa HealthCares PACE division signs agreement with CenterLight Healthcare PACEBRIEF-Tabula Rasa HealthCare's PACE division signs agreement with CenterLight Healthcare PACE
www.reuters.com - August 29 at 8:37 PM
Tabula Rasa subsidiary inks contract with largest U.S. managed care group for the elderly; shares ahead 9%Tabula Rasa subsidiary inks contract with largest U.S. managed care group for the elderly; shares ahead 9%
seekingalpha.com - August 29 at 8:37 PM
Tabula Rasa HealthCare’s PACE Division Signs Agreement with CenterLight Healthcare PACE to Manage Medication Risk, Improve Quality and OutcomesTabula Rasa HealthCare’s PACE Division Signs Agreement with CenterLight Healthcare PACE to Manage Medication Risk, Improve Quality and Outcomes
finance.yahoo.com - August 29 at 8:56 AM

Social Media

Financials

Chart

Tabula Rasa Healthcare (NASDAQ TRHC) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.